Showing results (211-220 of 284) with videos related to
Sort By:
Pageof 29
Clinical Transplantation|March 15, 2008
Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroidsAdele H Rike, Gautham Mogilishetty, Rita R Alloway, et al.Emerging Infectious Diseases|August 23, 2022
Fetal Loss and Preterm Birth Caused by Intraamniotic Haemophilus influenzae Infection, New ZealandThomas Hills, Caitlin Sharpe, Thomas Wong, et al.Cancer Chemotherapy and Pharmacology|May 21, 2021
Effects of strong and moderate CYP3A4 inducers on the pharmacokinetics of fedratinib in healthy adult participantsKen Ogasawara, Jeanelle Kam, Mark Thomas, et al.International Journal of Molecular Sciences|January 11, 2022
Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High ShearGina Perrella, Samantha J Montague, Helena C Brown, et al.Current Hypertension Reports|March 29, 2017
Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?Hamish Cg Prosser, Cynthia Gregory, Dagmara Hering, et al.Kidney & Blood Pressure Research|September 29, 2024
Assessing the Sympatholytic Effects of SGLT2 Inhibitors in Anuric Haemodialysis Patients Using Microneurography: Study Protocol for a Mechanistic Proof-of-Concept TrialAaron Yee Shuen See, Evgenija Blazeska, Awf Abdulrahman Shaban, et al.Chemistry & Biology|February 24, 2006
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug designGeorge Kontopidis, Campbell McInnes, Sravan R Pandalaneni, et al.Journal of the American Chemical Society|May 2, 2012
Interplay of metalloligand and organic ligand to tune micropores within isostructural mixed-metal organic frameworks (M'MOFs) for their highly selective separation of chiral and achiral small moleculesMadhab C Das, Qunsheng Guo, Yabing He, et al.Experimental Cell Research|February 8, 2008
Mighty is a novel promyogenic factor in skeletal myogenesisAmy Marshall, Mônica Senna Salerno, Mark Thomas, et al.The Journal of Endocrinology|December 9, 2020
IGF1 does not overcome sexual dimorphism of body and muscle size in Mstn-/- miceRyan Paul, Kim Whiteman, Shelley J Falconer, et al.Pageof 29